Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial

被引：0
作者：
Lisa M. Pitchford
Patricia M. Driver
John C. Fuller
Wendell S. Akers
Naji N. Abumrad
Venkataraman Amarnath
Ginger L. Milne
Sheau-Chiann Chen
Fei Ye
L. Jackson Roberts
M. Benjamin Shoemaker
John A. Oates
John A. Rathmacher
Olivier Boutaud
机构：
[1] MTI BioTech,Department of Kinesiology
[2] Inc.,Department of Medicine, Division of Clinical Pharmacology
[3] Iowa State University,Department of Pharmaceutical Sciences
[4] Vanderbilt University Medical Center,Department of Pharmacology, Division of Clinical Pharmacology
[5] Lipscomb University College of Pharmacy,Department of Surgery
[6] Vanderbilt University,Department of Biostatistics
[7] Vanderbilt University Medical Center,Department of Medicine, Division of Cardiology
[8] Vanderbilt University Medical Center,Department of Animal Science
[9] Vanderbilt University Medical Center,undefined
[10] Iowa State University,undefined
来源：
BMC Pharmacology and Toxicology | / 21卷
关键词：
Safety; Pharmacokinetics; Humans; Salicylamine; γ-Ketoaldehydes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Efficacy, Tolerability, and Immunogenicity of OnabotulinumtoxinA in a Randomized, Double-Blind, Placebo-Controlled Trial for Cervical Dystonia
    Charles, David
    Brashear, Allison
    Hauser, Robert A.
    Li, Hung-Ir
    Boo, Lee-Ming
    Brin, Mitchell F.
    CLINICAL NEUROPHARMACOLOGY, 2012, 35 (05) : 208 - 214
  • [42] Safety, tolerability, and pharmacokinetics of HRS9432(A) injection in healthy Chinese subjects: a phase-I randomized, double-blind, dose escalation, placebo-controlled study
    Yan, Xin
    Huang, Yuanyuan
    Xie, Jinlian
    Wu, Qian
    Yang, Shuang
    Yang, Xiaoyan
    Chen, Honghui
    Huang, Jie
    Yang, Guoping
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (07)
  • [43] A Randomized, Double-Blind, Placebo-Controlled, First-Time-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects
    Han, Kelong
    Cremer, Jennifer
    Elston, Robert
    Oliver, Stuart
    Baptiste-Brown, Sharon
    Chen, Shuguang
    Gardiner, David
    Davies, Matt
    Saunders, Joanne
    Hamatake, Robert
    Losos, Jan
    Leivers, Martin
    Hood, Steve
    van der Berg, Frans
    Paff, Melanie
    Ritter, James M.
    Theodore, Dickens
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (06): : 790 - 801
  • [44] A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX-02 in Healthy Subjects
    Leubitz, Andi
    Vanhoutte, Frederic
    Hu, Ming-yi
    Porter, Kaela
    Gordon, Efrat
    Tencer, Kathleen
    Campbell, Kathleen
    Banks, Kate
    Haverty, Tom
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (08): : 859 - 869
  • [45] Safety, tolerability, pharmacokinetics, and pharmacodynamics of a soluble guanylate cyclase stimulator, HEC95468, in healthy volunteers: a randomized, double-blinded, placebo-controlled phase 1 trial
    Gui, Yu-zhou
    Wang, Wei
    Wu, Qing-qing
    Ding, Qi-chen
    Qian, Hong-jie
    Lu, Qiu-bei
    Zhang, Ying-jun
    Zhuang, Yu-lei
    Deng, Li
    Zuo, Ying-lin
    Luo, Lin
    Jia, Jing-ying
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [46] Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Clinical Effect of Danirixin in Adults With Acute, Uncomplicated Influenza
    Roberts, Grace
    Chen, Shuguang
    Yates, Phillip
    Madan, Anuradha
    Walker, Jill
    Washburn, Michael L.
    Peat, Andrew J.
    Soucie, Gary
    Kerwin, Edward
    Roy-Ghanta, Sumita
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (04):
  • [47] Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega-3-Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase I Single-Blind, Randomized, Placebo-Controlled Trial
    Noda, Yoshinori
    Nilsson, Catarina
    Shimada, Hitoshi
    Kim, Hyosung
    Lundstrom, Torbjorn
    Yajima, Toshitaka
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (02): : 177 - 187
  • [48] Safety, tolerability, pharmacokinetics and neutrophil elastase inhibitory effects of Sivelestat: A randomized, double-blind, placebo-controlled singleand multiple-dose escalation study in Chinese healthy subjects
    Li, Kun
    Dong, Lingfang
    Gao, Shan
    Zhang, Jingying
    Feng, Yinghua
    Gu, Li
    Yang, Jie
    Liu, Xing
    Wang, Yaqin
    Mao, Zhenkun
    Jiang, Dandan
    Xia, Zhengchao
    Zhang, Guoliang
    Tang, Jingwen
    Ma, Peizhi
    Zhang, Wei
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 195
  • [49] Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial
    Hao, B.
    Chen, Z.
    Zeng, G.
    Huang, L.
    Luan, C.
    Xie, Z.
    Chen, J.
    Bao, M.
    Tian, X.
    Xu, B.
    Wang, Y.
    Wu, J.
    Xia, S.
    Yuan, L.
    Huang, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (08) : 1026 - 1031
  • [50] A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single Rising Doses 0.5 Mg to 500 Mg of BI409306 Administered Orally n Healthy Male Volunteers
    Moschetti, Viktoria
    Boland, Katja
    Feifel, Ulrich
    Hoch, Anja
    Zimdahl-Gelling, Heike
    Sand, Michael
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09)
12345